About
Company Profile
Company Introduction
R&D
Core Technology
PTS: Functional Mechanism
R&D Center
Paper Publish
History
Our Team
Partnership
Partnerships – Human Indication
Partnerships – Animal Drugs
News
Academic Activities
Product
Para-Toluenesulfonamide (PTS)
PTS: Functional Mechanism
Product Features
Comparison with existing cancer treatments
Market Position
R&D
PTS100
PTS500
PTS02
GWA103
GWA106
Pipeline
Clinical Trials
Product progress
Business Partnership
Partnerships – Human Indication
Partnerships – Animal Drugs
Investor zone
Important news
Financial area
Annual Report
Monthly Revenue
2025
2024
Consolidated Financial Reports
Shareholders area
Corporate Governance
Contact
下載產品DM
PTS Product Flyer
Gongwin Biopharm Brochure
LINKEDIN
YOUTUBE
GO
中文
EN
INQUIRY
(
)
中文
EN
下載產品DM
PTS Product Flyer
Gongwin Biopharm Brochure
SCROLL DOWN
Home
Investor Zone
Financial area
Annual Report
Annual Report
Annual Financial Report
Year
Item Download
2023 Annual Report
2023 Annual Report
2022 Annual Report
2022 Annual Report
2021 Annual Report
2021 Annual Report
2020 Annual Report
2020 Annual Report
2019 Annual Report
2019 Annual Report
2018 Annual Report
2018 Annual Report
2017 Annual Report
2017 Annual Report
2016 Annual Report
2016 Annual Report
Previous page
Back to list
Next page
TOP
